Search results
Results From The WOW.Com Content Network
In 2022, Cadila Healthcare Ltd was renamed as Zydus Lifesciences Ltd. [15] In October 2024, USFDA Approval for Prostate Cancer Drug: Zydus Lifesciences received USFDA approval to manufacture Enzalutamide tablets, which are used for treating prostate cancer. This drug, an androgen receptor inhibitor, is designed for patients with castration ...
Zydus Wellness (previously Carnation Nutra-Analogue Foods) is an Indian consumer goods company headquartered in Ahmedabad, which produces nutrition and skincare products. It is a subsidiary of the pharmaceutical company Zydus Lifesciences (formerly known as Cadila Healthcare).
Cadila Pharmaceuticals is an Indian multinational pharmaceutical company based in Ahmedabad. The company's operations focus on manufacturing products ranging from active pharmaceutical intermediates , finished formulations , food supplements, biotechnology products and pharmaceutical machinery.
Gujarat has become a hub for the pharmaceutical industry, with several established companies such as Torrent Pharmaceuticals, Zydus Lifesciences, Cadila Pharmaceuticals, Alembic Pharmaceuticals, Sun Pharma, Claris, Intas Pharmaceuticals, and Dishman Pharmaceuticals having operations in the state.
Zydus Hospitals & Healthcare Private Limited is a standalone project & a separate entity from Zydus lifesciences, It has acquired the Ahmedabad unit of Columbia Asia Hospital Pvt Ltd. Financial details of the transaction were not disclosed, however the speculated amount is about 100 crores. [3] [4]
Zydus, listed as Cadila Healthcare, joins other Indian pharmaceutical companies Cipla Ltd, Jubilant Sciences Ltd and privately held Hetero Labs Ltd in signing non-exclusive pacts with Gilead for ...
India's Zydus Cadila has sought regulatory approval for clinical trials of its antibody cocktail to treat mild COVID-19, as the country grapples with a shortage of medicines and vaccines needed to ...
In India, nebivolol is available as Nebula (Zydus Healthcare Ltd), Nebizok (Eris life-sciences), Nebicip (Cipla ltd), Nebilong (Micro Labs), Nebistar (Lupin ltd), Nebicard (Torrent), Nubeta (Abbott Healthcare Pvt Ltd – India), and Nodon (Cadila Pharmaceuticals). In Greece and Italy, nebivolol is marketed by Menarini as Lobivon.